+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dermatitis"

Sebohrrea - Pipeline Insight, 2025 - Product Thumbnail Image

Sebohrrea - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
From
Dermatology Devices Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Dermatology Devices Market - Forecasts from 2025 to 2030

  • Report
  • May 2025
  • 142 Pages
  • Global
From
From
From
From
From
From
Atopic Dermatitis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Atopic Dermatitis Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 1432 Pages
  • Global
From
From
From
From
Loading Indicator

Dermatitis is a broad term used to describe a range of skin conditions that cause inflammation, redness, and itching. It is a common skin disorder that affects people of all ages and can be caused by a variety of factors, including allergies, irritants, and infections. Treatment for dermatitis typically involves the use of topical medications, such as corticosteroids, antibiotics, and antihistamines. In some cases, phototherapy may be used to reduce inflammation. The dermatitis market is an important part of the dermatology industry, as it is estimated that up to 20% of the population suffers from some form of dermatitis. The market is highly competitive, with a wide range of products available to treat the condition. Companies in the dermatitis market include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Novartis. Show Less Read more